Pharmaceutical Technology

JUNE 6, 2025

The approval process for cell and gene therapy candidates is tricky, however, given their high-cost and oft-debated benefit-risk ratio. RFK Jr did not question their importance, and acknowledged panellists’ calls for faster regulatory processes. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 7, 2025

This alliance seeks to bolster clinical trial capabilities through improved regulatory processes and data governance. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. They aim to develop patient-specific treatment protocols while ensuring adherence to rigorous international standards.

Hospitals

Pharmaceutical Technology

JUNE 20, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content. Give your business an edge with our leading industry insights.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 1, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. AbbVie’s purchase comes just a few days after the US Food and Drug Administration (FDA) removed an access barrier for currently approved CAR-T therapies, regarded as a boost to the sector’s outlook.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 30, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. This update also suggests we may not see REMS requirements for CD19 and BCMA autologous CAR-T cell therapies in the future,” the research note added. Editorial content is independently produced and follows the highest standards of journalistic integrity.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 9, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. JCR has also developed a proprietary blood-brain barrier-penetrating technology, J-Brain Cargo, to deliver biotherapeutics into the central nervous system. Topic sponsors are not involved in the creation of editorial content.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 14, 2025

Robert Barrie July 14, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Broader label coverages for Pfizer and Moderna’s vaccines mean they have made in-roads into GSK’s RSV dominant market share. MAXSHOT.PL via Shutterstock. Give your business an edge with our leading industry insights.

Labelling

Pharmaceutical Technology

JULY 22, 2025

It is important for the patients we serve that Sarepta maintains a productive and positive working relationship with FDA, and it became obvious that maintaining that productive working relationship required this temporary suspension while we address any questions that FDA may have and complete the Elevidys label supplement process.”

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 29, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Despite being a different drug, it is built on the same viral vector as Elevidys, a recombinant adeno-associated viral vector (AAV) called AAVrh74. Editorial content is independently produced and follows the highest standards of journalistic integrity.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 14, 2025

The company is confident that these concerns, which pertain to facilities and processes rather than product quality, can be promptly addressed. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Efforts are underway to work with the FDA to resolve them.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 25, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. GlobalData is the parent company of Clinical Trials Arena. Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 16, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content. Give your business an edge with our leading industry insights.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 17, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Elsewhere in the partnership arena, AstraZeneca outlaid $5.2bn to enlist the services of China-based CSPC Pharmaceuticals. In addition, BMS earmarked $11bn earlier this month to join BioNTech’s development of a bispecific cancer drug.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 30, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. His exit raises critical questions: which evidence standards will prevail: traditional or accelerated?” commented Cynthia Pussinen, CEO of Owl Bio Advisors, a life sciences consultancy group. Give your business an edge with our leading industry insights.

Insurance Coverage and Processing

pharmaphorum

JULY 7, 2025

Skip to main content Monday 7 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 17, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content. Give your business an edge with our leading industry insights.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 20, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content. Give your business an edge with our leading industry insights.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 13, 2025

mRNA vaccine coverage on Pharmaceutical Technology (or Clinical Trials Arena) is supported by Trilink. GSK also has an FDA-approved vaccine in the form of Arexvy, though its label only covers those at risk in individuals aged between 50 through 59 years , along with the standard indication of ages 60 and over.

Vaccines

Pharmaceutical Technology

AUGUST 7, 2025

mRNA vaccine coverage on Pharmaceutical Technology (or Clinical Trials Arena) is supported by Trilink. Shares of key sector players such as Moderna and BioNTech remain stable, with values reducing by 2.8% and increasing by 0.21% respectively, suggesting that investors still have hope for the modality.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 23, 2025

Better insights into how SDoH affects health can highlight the systemic influences that leave certain groups with worse health outcomes than others, despite similar health insurance coverage or access. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 10, 2025

Disrupting ACIP’s work introduces dangerous uncertainty about which vaccines will continue to be covered and whether families will have to pay out of pocket for routine immunisations,” the non-profit said. Give your business an edge with our leading industry insights.

Vaccines

Pharmaceutical Technology

JUNE 12, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. In 2023, SpliceBio signed a licensing agreement with Spark Therapeutics, allowing the latter to use its protein splicing platform and develop a gene therapy for an undisclosed inherited renal disease.

Insurance Coverage and Processing

Pharmaceutical Technology

NOVEMBER 30, 2022

In the US, most private health insurers have been slow to cover the cost of anti-obesity therapeutics. Medicare Part A, Part B, and Part D do not generally cover approved weight loss medications like Saxenda, but Medicare Advantage plans may allow for expanded coverage, as per the Medicare.org site.

Insurance Coverage and Processing

Pharmaceutical Technology

NOVEMBER 30, 2022

In the US, most private health insurers have been slow to cover the cost of anti-obesity therapeutics. Medicare Part A, Part B, and Part D do not generally cover approved weight loss medications like Saxenda, but Medicare Advantage plans may allow for expanded coverage, as per the Medicare.org site.

Insurance Coverage and Processing

Pharmaceutical Technology

FEBRUARY 7, 2023

Launching a new drug can be a risky business, with regulatory approval no guarantee that private, commercial, and government-funded insurers will reimburse it. Meanwhile, in Germany, the AMNOG process is conducted twelve months after the drug is launched, thus giving freedom to the company to set the drug’s price during this period.

Insurance Coverage and Processing